| NCT07201129 | A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment | NOT_YET_RECRUITING | PHASE3 | 2025-12 | 2030-02 | 2029-08 |
| NCT07133191 | A Trial to Compare What the Body Does to Selatogrel and the Effect of Selatogrel in Japanese and Caucasian Healthy Participants | NOT_YET_RECRUITING | PHASE1 | 2025-09 | 2025-10 | 2025-10 |
| NCT06672016 | Study to Evaluate Contraceptive Efficacy and Safety of a Progestin Only Patch in Women of Childbearing Potential | RECRUITING | PHASE3 | 2025-01-13 | 2027-04 | 2027-03 |
| NCT06475742 | Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus | ENROLLING_BY_INVITATION | PHASE3 | 2024-07-30 | 2028-05 | 2028-05 |
| NCT06400511 | A Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment | ACTIVE_NOT_RECRUITING | PHASE3 | 2024-04-22 | 2025-12 | 2025-11 |
| NCT06273254 | A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions | NOT_YET_RECRUITING | PHASE1 | 2024-04 | 2024-09 | 2024-05 |
| NCT06266988 | A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions | NOT_YET_RECRUITING | PHASE1 | 2024-03 | 2024-08 | 2024-04 |
| NCT06215820 | Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Bunionectomy | COMPLETED | PHASE3 | 2023-12-29 | 2024-09-30 | 2024-08-24 |
| NCT06215859 | Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Herniorrhaphy | COMPLETED | PHASE3 | 2023-12-29 | 2025-03-12 | 2025-01-31 |
| NCT06048536 | Dose-finding Study of MR-130A-01 Contraceptive Transdermal Patch | COMPLETED | PHASE2 | 2023-12-22 | 2024-01-18 | 2024-01-18 |
| NCT06126952 | Azelastine Allergen Chamber - Onset of Action Study | COMPLETED | PHASE2 | 2023-10-30 | 2024-03-18 | 2024-02-23 |
| NCT05672576 | A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus | RECRUITING | PHASE3 | 2023-06-26 | 2027-05-01 | 2026-10-31 |
| NCT05648500 | A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus | RECRUITING | PHASE3 | 2022-12-13 | 2027-05-01 | 2026-10-31 |
| NCT05317312 | Study of MR-107A-02 in the Treatment of Post Surgical Dental Pain. | COMPLETED | PHASE2 | 2022-03-31 | 2022-06-20 | 2022-06-15 |
| NCT05046795 | Revefenacin in Chinese Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease(COPD) | COMPLETED | PHASE3 | 2021-11-10 | 2023-07-26 | 2023-07-26 |
| NCT05139121 | Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles | COMPLETED | PHASE3 | 2021-10-26 | 2025-01-15 | 2025-01-15 |
| NCT05004311 | The Effect of Severe Kidney Impairment on Cenerimod Pharmacokinetics | COMPLETED | PHASE1 | 2021-09-27 | 2023-08-10 | 2023-07-27 |
| NCT05207111 | Fasting Bioavailability Study of Mylan's Revefenacin Inhalation Solution | COMPLETED | PHASE1 | 2021-09-23 | 2021-09-30 | 2021-09-30 |
| NCT04819464 | A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of Cenerimod | COMPLETED | PHASE1 | 2021-08-25 | 2024-08-18 | 2024-08-18 |
| NCT04957719 | Selatogrel Outcome Study in Suspected Acute Myocardial Infarction | ENROLLING_BY_INVITATION | PHASE3 | 2021-08-14 | 2026-12 | 2026-12 |
| NCT05030025 | Abacavir, Dolutegravir and Lamivudine Dispersible Tablets (60 mg/5 mg/30 mg) | COMPLETED | EARLY_PHASE1 | 2021-08-01 | 2021-08-29 | 2021-08-29 |
| NCT05053126 | Study Evaluating Abuse Potential of Lyrica® in Healthy Non-Drug Dependent Recreational Opioid Users | COMPLETED | PHASE4 | 2021-07-27 | 2022-04-01 | 2022-04-01 |
| NCT05319756 | Study Evaluating the Abuse Potential of NEURONTIN® in Healthy Non-drug Dependent, Recreational Opioid Users | COMPLETED | PHASE4 | 2021-04-30 | 2021-12-31 | 2021-12-31 |
| NCT04570436 | Evaluating the Abuse Potential of NEURONTIN® When Taken Orally in Healthy Non-drug Dependent Participants With Sedative Drug Abuse Experience | COMPLETED | PHASE4 | 2021-03-29 | 2022-11-10 | 2022-11-10 |
| NCT04652245 | Dymista Allergen Chamber - Onset of Action Study | COMPLETED | PHASE4 | 2020-12-14 | 2021-12-13 | 2021-12-04 |
| NCT04674800 | Extension Study of MYL-1701P-3001 for Safety and Efficacy | COMPLETED | PHASE3 | 2020-11-23 | 2022-04-20 | 2022-04-20 |
| NCT04557280 | A Comparative Study of Selatogrel (ACT-246475) Formulations in Healthy Subjects | COMPLETED | PHASE1 | 2020-11-06 | 2020-12-19 | 2020-12-19 |
| NCT04571515 | Dose-Response Study of MR-107A-01 in The Treatment of Post-Surgical Dental Pain | COMPLETED | PHASE2 | 2020-09-29 | 2020-12-22 | 2020-12-15 |
| NCT04406896 | The Effect of Reduced Liver Function on Selatogrel Pharmacokinetics | COMPLETED | PHASE1 | 2020-07-22 | 2020-10-23 | 2020-10-23 |
| NCT04255277 | To Study the Effect of Cenerimod on the Electrical Activity of the Heart, in Men and Women. To Study the Effect of Cenerimod on the Use of Oral Contraceptives in Women. To Study the Effect That Charcoal Has on the Elimination of Cenerimod From the Body, in Women and Men. | COMPLETED | PHASE1 | 2020-01-31 | 2021-10-18 | 2021-09-14 |
| NCT04052360 | Single Oral Dose of 4 mg Cenerimod in Healthy Japanese and Caucasian Subjects | COMPLETED | PHASE1 | 2019-08-07 | 2019-11-02 | 2019-10-29 |
| NCT03814200 | A Study to Investigate the Effect of Rifampicin on the Uptake and Breakdown of ACT-246475 in Healthy Subjects | COMPLETED | PHASE1 | 2019-01-03 | 2019-02-19 | 2019-02-12 |
| NCT03742037 | Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus | COMPLETED | PHASE2 | 2018-12-21 | 2022-08-25 | 2021-08-31 |
| NCT03760068 | Mylan Insulin Aspart Study | COMPLETED | PHASE3 | 2018-11-07 | 2020-01-17 | 2019-12-28 |
| NCT03610646 | Comparative Study to Evaluate the Efficacy and Safety of MYL-1701P and Eylea® in Subjects With Diabetic Macular Edema (DME) | COMPLETED | PHASE3 | 2018-08-23 | 2021-09-10 | 2020-11-10 |
| NCT03593278 | A Study to Evaluate ACT-246475 Fate in Healthy Male Subjects | COMPLETED | PHASE1 | 2018-07-27 | 2018-08-05 | 2018-08-05 |
| NCT03487445 | A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Heart Attack | COMPLETED | PHASE2 | 2018-07-10 | 2018-11-10 | 2018-11-10 |
| NCT03599791 | DYmista NAsal Spray in CHInese Patients | COMPLETED | PHASE3 | 2018-06-29 | 2019-09-24 | 2019-09-24 |
| NCT03502070 | Human Factors Study to Validate the User Interface of TOBI Podhaler Using Placebo Capsules | COMPLETED | PHASE4 | 2018-06-26 | 2019-06-17 | 2019-03-19 |
| NCT03573817 | A 42-day Parallel Group Safety Study of Revefenacin and Formoterol, Administered in Sequence and as a Combination, in Participants With COPD | COMPLETED | PHASE3 | 2018-05-31 | 2018-09-25 | 2018-09-25 |
| NCT03384966 | A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease | COMPLETED | PHASE2 | 2018-01-24 | 2018-09-18 | 2018-08-18 |
| NCT03430661 | A Study to Investigate the Interaction Between ACT-246475 and Clopidogrel, Prasugrel, and Ticagrelor in Healthy Subjects | COMPLETED | PHASE1 | 2018-01-24 | 2019-05-29 | 2019-05-20 |
| NCT03376789 | Mylan Insulin Glargine Study | COMPLETED | PHASE3 | 2017-11-29 | 2019-01-10 | 2018-09-25 |
| NCT03172780 | A Bioequivalence Study Using Clinical Endpoint for Diclofenac Sodium Gel 1% in Osteoarthritis Knee" | COMPLETED | PHASE3 | 2017-05-24 | 2017-12-05 | 2017-12-05 |
| NCT03095456 | Revefenacin Peak Inspiratory Flow Rate (PIFR) Study in COPD | COMPLETED | PHASE3 | 2017-03-27 | 2017-11-25 | 2017-11-25 |
| NCT04633564 | MYL-1402O Compared With Avastin®, in Patients With Stage IV nsNSCLC | COMPLETED | PHASE3 | 2017-01-21 | 2019-11-22 | 2019-06-05 |
| NCT03004131 | MP-AzeFlu Allergen Chamber - Onset of Action Study | COMPLETED | PHASE4 | 2017-01-07 | 2017-03-29 | 2017-03-29 |
| NCT03173625 | A Study Conducted in Healthy Male Subjects to Investigate the Safety and Tolerability of AC-76, Its Fate in the Body, and Its Effect on the Body | COMPLETED | PHASE1 | 2016-11-29 | 2017-04-15 | 2017-04-15 |
| NCT02914223 | A Study to Evaluate Cenerimod in Healthy Male Subjects | COMPLETED | PHASE1 | 2016-09-01 | 2016-12-01 | 2016-12-01 |
| NCT02820311 | Thorough QT (TQT) Study of TD-4208 in Healthy Subjects | COMPLETED | PHASE1 | 2016-05 | 2016-07 | 2016-07 |
| NCT03129321 | Therapeutic Equivalence and Safety of Two Econazole Nitrate Cream, 1% Products in Tinea Pedis | COMPLETED | PHASE3 | 2016-03-15 | 2016-11-17 | 2016-11-17 |
| NCT03107611 | Bioequivalence Study of Pimecrolimus Cream, 1% and Elidel® Cream, 1% in Mild to Moderate Atopic Dermatitis | COMPLETED | PHASE3 | 2016-02-29 | 2017-05-15 | 2017-05-15 |
| NCT02666430 | Extension Study to Assess Safety and Efficacy of Mylan's Insulin Glargine and Lantus® in Type 1 Diabetes Mellitus (T1DM) Patients | COMPLETED | PHASE3 | 2015-12 | 2017-07 | 2017-03 |
| NCT02578082 | Pharmacokinetics of TD-4208 in Patients With Severe Renal Impairment | COMPLETED | PHASE1 | 2015-12 | 2016-05 | 2016-05 |
| NCT02581592 | Pharmacokinetics of TD-4208 in Patients With Moderate Hepatic Impairment | COMPLETED | PHASE1 | 2015-11 | 2016-04 | 2016-04 |
| NCT02518139 | A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2015-09 | 2017-06 | 2017-06 |
| NCT02512510 | Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2015-09 | 2016-09 | 2016-08 |
| NCT02459080 | Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 | 2015-09 | 2016-09 | 2016-08 |
| NCT02714322 | MYL-1401A Efficacy and Safety Comparability Study to Humira® | COMPLETED | PHASE3 | 2015-06 | 2017-03 | 2016-05 |
| NCT02772159 | TD-4208 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects | COMPLETED | PHASE1 | 2015-06 | 2016-04 | 2016-04 |
| NCT02472795 | Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus Erythematosus | COMPLETED | PHASE1, PHASE2 | 2015-06-01 | 2017-02-28 | 2017-01-23 |
| NCT02474017 | An Open Study to Assess the Robustness of the CRC749 Inhaler | COMPLETED | PHASE1 | 2015-05 | 2015-06 | 2015-06 |
| NCT02479204 | Clinical Study to Investigate Safety and Effects on Heart Rate, Blood Pressure, and Pharmacokinetic Interactions of ACT-334441 | TERMINATED | PHASE1 | 2015-04-28 | 2016-05-01 | 2016-05-01 |
| NCT02469987 | Phase I - Pharmacokinetic Comparability Study in Healthy Male Volunteers | COMPLETED | PHASE1 | 2015-04 | 2015-10 | 2015-10 |
| NCT02467868 | Efficacy and Safety Study With MYL-1401H and Neulasta | COMPLETED | PHASE3 | 2015-03 | 2016-02 | 2015-09 |
| NCT02472912 | Adalimumab PK Bioequivalence Study to EU and US Sourced Humira | COMPLETED | PHASE1 | 2014-12 | 2015-06 | 2015-05 |
| NCT02322710 | Comparison of Efficacy on Healing, and Safety of Two Dressings Urgotul and TulleGras MS on Surgical Acute Wounds. | COMPLETED | NA | 2014-12 | 2016-11 | 2016-11 |
| NCT02245672 | MGR001 / Advair Diskus Local Equivalence Study in Asthma | COMPLETED | PHASE3 | 2014-10 | 2015-07 | 2015-07 |
| NCT02479646 | Pharmacokinetic / Pharmacodynamic Study Comparing MYL-1401H, EU-sourced Neulasta and US-licensed Neulasta | COMPLETED | PHASE1 | 2014-09 | 2015-06 | 2015-06 |
| NCT02227875 | Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 2 Diabetes Mellitus Patients (INSTRIDE 2) | COMPLETED | PHASE3 | 2014-08 | 2015-12 | 2015-12 |
| NCT02227862 | Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 1 Diabetes Mellitus Patients (INSTRIDE 1) | COMPLETED | PHASE3 | 2014-06 | 2016-07 | 2016-07 |
| NCT02195986 | A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis | COMPLETED | PHASE3 | 2014-06 | 2014-12 | 2014-12 |
| NCT02040792 | A 28-Day Parallel Group Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE2 | 2014-05 | 2014-08 | 2014-07 |
| NCT02094716 | A Dose Ranging Vehicle Controlled Study to Determine the Safety and Efficacy of Permethrin Foam, 5% and Permethrin Foam, 4% for the Treatment of Scabies | COMPLETED | PHASE2 | 2014-04 | 2014-12 | 2014-12 |
| NCT02109172 | A 7-Day Cross-over Study of QD (Once Daily) and BID (Twice Daily) TD-4208 in Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE2 | 2014-04 | 2014-10 | 2014-09 |
| NCT02104180 | Evaluation of Pain Associated With the Removal of Wound Dressing During Care of Venous Leg Ulcer. Comparison of the Efficacy and Safety of Two Dressings Urgotul and TulleGras | COMPLETED | NA | 2014-02 | 2016-03 | 2016-03 |
| NCT02215122 | Bioequivalence Study to Assess Systemic Exposure of FP and SAL FDC From Different DPIs | COMPLETED | PHASE1 | 2013-10 | 2013-11 | 2013-11 |
| NCT01704404 | 7 Days of TD-4208 in Subjects With Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE2 | 2012-12 | 2013-12 | 2013-11 |
| NCT02472964 | Study of Efficacy and Safety of Myl1401O + Taxane vs Herceptin©+ Taxane for 1st Line, Met. Br. Ca. | COMPLETED | PHASE3 | 2012-07 | 2018-08 | 2016-03 |
| NCT01453179 | Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2) | COMPLETED | PHASE4 | 2011-10 | 2015-03 | 2015-03 |
| NCT03064113 | Effects of TD-4208 on FEV1 in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE2 | 2011-05 | 2011-10 | 2011-10 |
| NCT01336530 | Tepilta® Versus Oxetacaine, Antacids and Placebo | TERMINATED | PHASE3 | 2011-04 | 2017-01 | 2017-01 |
| NCT01256086 | Relative Potency of Formoterol Novolizer® 12 µg Compared to Formoterol Aerolizer® 12 µg | COMPLETED | PHASE2 | 2010-12 | 2011-07 | 2011-07 |
| NCT01194622 | Single Dose Pharmacokinetics of Intranasal Fluticasone Delivered by a Fixed Combination With Azelastine (MP29 02) in Comparison to Two Different Fluticasone Nasal Sprays | COMPLETED | PHASE1 | 2010-08 | 2010-10 | 2010-10 |
| NCT01190852 | Single Dose Pharmacokinetics of Intranasal Azelastine Delivered by a Fixed Combination With Fluticasone in Comparison to Azelastine Nasal Sprays | COMPLETED | PHASE1 | 2010-08 | 2010-10 | 2010-10 |
| NCT00915681 | Intravenous Milk Thistle (Silibinin-Legalon) for Hepatic Failure Induced by Amatoxin/Amanita Mushroom Poisoning | TERMINATED | PHASE2 | 2009-11-10 | 2020-04-10 | 2020-04-10 |
| NCT00777127 | Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses | COMPLETED | PHASE4 | 2008-12 | 2012-11 | 2012-11 |
| NCT00777348 | To Assess the Protective Effect of the Fixed Drug Combination of Disodium Cromoglycate Plus Reproterol | COMPLETED | PHASE2 | 2007-11 | 2008-10 | 2008-10 |
| NCT00634166 | Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control Group | TERMINATED | PHASE4 | 2007-09 | 2014-04 | 2013-12 |
| NCT00650520 | Fed Study of (Parlodel®) 2.5 mg Bromocriptine Mesylate Tablets | COMPLETED | PHASE1 | 2007-05 | 2007-07 | 2007-07 |
| NCT00649168 | Fed Study of (Parlodel®) Bromocriptine Mesylate Capsules 5 mg | COMPLETED | PHASE1 | 2007-04 | 2007-06 | 2007-06 |
| NCT00648882 | Fasting Study of Levothyroxine Sodium Tablets 300 mcg to Synthroid® Tablets 300 mcg | COMPLETED | PHASE1 | 2007-03 | 2007-05 | 2007-04 |
| NCT00649480 | Fed Study of Balsalazide Disodium Capsules 750 mg and Colazal® Capsules 750 mg | COMPLETED | PHASE1 | 2007-01 | 2007-02 | 2007-02 |
| NCT00648193 | Fasting Study of Paroxetine Hydrochloride Tablets 40 mg and Paxil® Tablets 40 mg | COMPLETED | EARLY_PHASE1 | 2006-12 | 2007-01 | 2006-12 |
| NCT00650403 | Food Study of Paroxetine Hydrochloride Tablets 40 mg and Paxil® Tablets 40 mg | COMPLETED | PHASE1 | 2006-12 | 2007-01 | 2006-12 |
| NCT01020214 | Fasting Study of Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg and Benicar HCT® Tablets 40 mg/25 mg | COMPLETED | PHASE1 | 2006-11 | 2006-11 | 2006-11 |
| NCT01019590 | Fed Study of Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg and Benicar HCT® Tablets 40 mg/25 mg | COMPLETED | PHASE1 | 2006-11 | 2006-11 | 2006-11 |
| NCT00650117 | Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System | COMPLETED | PHASE1 | 2006-10 | 2006-10 | 2006-10 |
| NCT00648414 | Study of the Effect of Clinical Procedures on Drug Delivery of Mylan Fentanyl Transdermal System 25 µg/hr and Duragesic® 25 µg/hr | TERMINATED | PHASE1 | 2006-10 | | 2006-10 |
| NCT00648297 | Fed Study of Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg and Corzide® Tablets 80 mg/5 mg | COMPLETED | PHASE1 | 2006-08 | 2006-08 | 2006-08 |
| NCT00647660 | Fasting Study of Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg and Corzide® Tablets 80 mg/5 mg | COMPLETED | PHASE1 | 2006-07 | 2006-08 | 2006-08 |
| NCT00647686 | Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System With Askina Derm Overlay | COMPLETED | PHASE1 | 2006-06 | 2006-07 | 2006-07 |
| NCT00648050 | Fasting Study of Verapamil HCl Extended-Release Capsules 300 mg to Verelan® PM Extended-Release Capsules 300 mg | COMPLETED | PHASE1 | 2006-03 | 2006-03 | 2006-03 |
| NCT00647959 | Fasting Study of Doxycycline Monohydrate Tablets 150 mg and Adoxa Tablets 150 mg | COMPLETED | PHASE1 | 2006-03 | 2006-04 | 2006-03 |
| NCT00649636 | Fasting Study of Fluoxetine Capsules 40 mg and Prozac Pulvules 40 mg | COMPLETED | PHASE1 | 2006-02 | 2006-04 | 2006-04 |
| NCT00294320 | Evaluation of Two Different Non-invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions | COMPLETED | PHASE3 | 2006-02 | 2007-01 | 2007-01 |
| NCT00648401 | Food Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Extended-Release Capsules 300 mg | COMPLETED | PHASE1 | 2006-01 | 2006-02 | 2006-01 |
| NCT00649272 | Fasting Study of Oxybutynin Chloride Extended-Release Tablets 15 mg and Ditropan XL® Tablets 15 mg | COMPLETED | PHASE1 | 2006-01 | 2006-02 | 2006-01 |
| NCT00647673 | Fasting Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Extended-Release Capsules 300 mg | COMPLETED | PHASE1 | 2006-01 | 2006-02 | 2006-01 |
| NCT00649805 | Fasting Applesauce Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Extended-Release Capsules 300 mg | COMPLETED | PHASE1 | 2006-01 | 2006-02 | 2006-01 |
| NCT00648219 | Fed Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mg | COMPLETED | PHASE1 | 2005-12 | 2006-01 | 2005-12 |
| NCT00649623 | Fasting Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mg | COMPLETED | PHASE1 | 2005-12 | 2005-12 | 2005-12 |
| NCT00649155 | Fasting Study of Ciprofloxacin Extended-Release Tablets 500 mg and Cipro® XR Tablets 500 mg | COMPLETED | PHASE1 | 2005-11 | 2005-11 | 2005-11 |
| NCT00648934 | Fed Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg | COMPLETED | PHASE1 | 2005-11 | 2005-12 | 2005-12 |
| NCT00647842 | Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System | COMPLETED | PHASE1 | 2005-11 | 2006-02 | 2006-02 |
| NCT00649467 | Applesauce Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg | COMPLETED | PHASE1 | 2005-11 | 2005-12 | 2005-12 |
| NCT00649740 | Fasting Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg | COMPLETED | PHASE1 | 2005-11 | 2005-12 | 2005-12 |
| NCT00649324 | Fasting Study of Hydrochlorothiazide Tablets 50 mg to Hydrochlorothiazide Tablets 50 mg | COMPLETED | EARLY_PHASE1 | 2005-10 | 2005-10 | 2005-10 |
| NCT00647621 | Steady-State Study of Extended Phenytoin Sodium Capsules 100 mg and Dilantin® Kapseals® 100 mg | COMPLETED | PHASE1 | 2005-10 | 2005-12 | 2005-12 |
| NCT00649662 | Fasting Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mg | COMPLETED | PHASE1 | 2005-10 | 2005-10 | 2005-10 |
| NCT00650351 | Food Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mg | COMPLETED | PHASE1 | 2005-10 | 2005-10 | 2005-10 |
| NCT00649987 | Fed Study of Albuterol Sulfate Extended-Release Tablets 8 mg and VoSpire® ER Tablets 8 mg | COMPLETED | PHASE1 | 2005-09 | 2005-10 | 2005-10 |
| NCT00647816 | Fasting Study of Propranolol Hydrochloride Extended-Release Capsules 160 mg and Inderal® LA Capsules 160 mg | COMPLETED | PHASE1 | 2005-09 | 2005-09 | 2005-09 |
| NCT00647608 | Food Study of Propranolol Hydrochloride Extended-Release Capsules 160 mg and Inderal® LA Capsules 160 mg | COMPLETED | PHASE1 | 2005-09 | 2005-10 | 2005-10 |
| NCT00650494 | Fed Study of Valacyclovir Hydrochloride Tablets 1000 mg and Valtrex® Tablets 1000 mg | COMPLETED | PHASE1 | 2005-08 | 2005-08 | 2005-08 |
| NCT00648700 | Fasting Study of Levothyroxine Sodium Tablets 300 μg to Levothroid® Tablets 300 μg | COMPLETED | PHASE1 | 2005-08 | 2005-09 | 2005-09 |
| NCT00649571 | Fasting Study of Doxycycline Monohydrate Tablets 100 mg and Adoxa Tablets 100 mg | COMPLETED | PHASE1 | 2005-07 | 2005-07 | 2005-07 |
| NCT00648804 | Food Study of Ondansetron Orally Disintegrating Tablets 8 mg to Zofran ODT® Tablets 8 mg | COMPLETED | PHASE1 | 2005-07 | 2005-07 | 2005-07 |
| NCT00648180 | Food Study of Doxycycline Monohydrate Tablets 100 mg and Adoxa Tablets 100 mg | COMPLETED | PHASE1 | 2005-07 | 2005-08 | 2005-08 |
| NCT00649363 | Fasting Study of Ondansetron Orally Disintegrating Tablets 8 mg to Zofran ODT® Tablets 8 mg | COMPLETED | PHASE1 | 2005-07 | 2005-07 | 2005-07 |
| NCT00649454 | Fasting Study of Glipizide and Metformin HCl Tablets 5 mg/500 mg to Metaglip® Tablets 5 mg/500 mg | COMPLETED | PHASE1 | 2005-06 | 2005-06 | 2005-06 |
| NCT00648505 | Food Study of Glipizide and Metformin HCl Tablets 5 mg/500 mg to Metaglip® Tablets 5 mg/500 mg | COMPLETED | PHASE1 | 2005-06 | 2005-06 | 2005-06 |
| NCT00189293 | Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts | COMPLETED | PHASE4 | 2005-06 | 2007-12 | 2007-12 |
| NCT00649870 | Food Study of Valacyclovir Hydrochloride Tablets 1000 mg to Valtrex® Tablets 1000 mg | COMPLETED | PHASE1 | 2005-05 | 2005-06 | 2005-05 |
| NCT00649935 | Fed Study of Azithromycin Tablets 600 mg to Zithromax® Tablets 600 mg | COMPLETED | PHASE1 | 2005-05 | 2005-06 | 2005-05 |
| NCT00649974 | Fasting Study of Valacyclovir Hydrochloride Tablets 1000 mg and Valtrex® Tablets 1000 mg | COMPLETED | PHASE1 | 2005-05 | 2005-05 | 2005-05 |
| NCT00650273 | Fasting Study of Azithromycin Tablets 600 mg to Zithromax® Tablets 600 mg | COMPLETED | PHASE1 | 2005-04 | 2005-05 | 2005-05 |
| NCT00648427 | Fasting Study of Paroxetine Hydrochloride Controlled-Release Tablets 25 mg to Paxil CR™ Tablets 25 mg | COMPLETED | PHASE1 | 2005-04 | 2005-05 | 2005-04 |
| NCT00647881 | Food Study of Paroxetine Hydrochloride Controlled-Release Tablets 25 mg to Paxil CR™ Tablets 25 mg | COMPLETED | PHASE1 | 2005-04 | 2005-05 | 2005-05 |
| NCT00328601 | Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Symptomatic Diabetic Neuropathy (SYDNEY 2) | COMPLETED | PHASE3 | 2005-02 | 2005-06 | |
| NCT00647894 | Fasting Study of Alprazolam Extended-Release Tablets 1 mg to Xanax XR Tablets 1 mg | COMPLETED | PHASE1 | 2005-01 | 2005-01 | 2005-01 |
| NCT00648947 | Fasting Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mg | COMPLETED | PHASE1 | 2004-12 | 2004-12 | 2004-12 |
| NCT00650169 | Food Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mg | COMPLETED | PHASE1 | 2004-12 | 2005-01 | 2005-01 |
| NCT00649818 | Fasting Study of Lorazepam Tablets 2 mg and Ativan Tablets 2 mg | COMPLETED | PHASE1 | 2004-12 | 2004-12 | 2004-12 |
| NCT00648362 | Fasting Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg | COMPLETED | PHASE1 | 2004-11 | 2004-12 | 2004-11 |
| NCT00650533 | Food Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg | COMPLETED | PHASE1 | 2004-11 | 2004-12 | 2004-12 |
| NCT00650377 | Fed Study of Finasteride Tablets 5 mg and Proscar® Tablets 5 mg | COMPLETED | PHASE1 | 2004-10 | 2004-10 | 2004-10 |
| NCT00648791 | Fasting Study of Finasteride Tablets 5 mg and Proscar Tablets 5 mg | COMPLETED | PHASE1 | 2004-09 | 2004-10 | 2004-10 |
| NCT00648661 | Food Study of Escitalopram Oxalate Tablets 20 mg to Lexapro® Tablets 20 mg | COMPLETED | PHASE1 | 2004-09 | 2004-10 | 2004-10 |
| NCT00650299 | Fed Study of Alprazolam Extended-release Tablets 3 mg to Xanax XR® Tablets 3 mg | COMPLETED | PHASE1 | 2004-08 | 2004-08 | 2004-08 |
| NCT00648570 | Fasting Study of Escitalopram Oxalate Tablets 20 mg and Lexapro® Tablets 20 mg | COMPLETED | PHASE1 | 2004-08 | 2004-10 | 2004-10 |
| NCT00647634 | Fasting Study of Alprazolam Extended-Release Tablets 3 mg to Xanax XR® Tablets 3 mg | COMPLETED | PHASE1 | 2004-08 | 2004-08 | 2004-08 |
| NCT00649675 | Food Study of Meloxicam Tablets 15 mg and Mobic® Tablets 15 mg | COMPLETED | PHASE1 | 2004-08 | 2004-09 | 2004-09 |
| NCT00649077 | Fasting Study of Meloxicam Tablets 15 mg and Mobic® Tablets 15 mg | COMPLETED | PHASE1 | 2004-08 | 2004-09 | 2004-09 |
| NCT00647751 | Food Study of Lamotrigine Tablets 25 mg to Lamictal® Tablets 25 mg | COMPLETED | PHASE1 | 2004-08 | 2004-08 | 2004-08 |
| NCT00650208 | Fasting Study of Lamotrigine Tablets 25 mg to Lamictal® Tablets 25 mg | COMPLETED | PHASE1 | 2004-07 | 2004-08 | 2004-08 |
| NCT00648531 | Fasting Study of Balsalazide Disodium Capsules 750 mg and Colazal® Capsules 750 mg | COMPLETED | PHASE1 | 2004-05 | 2004-05 | 2004-05 |
| NCT00649519 | Fasting Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg | COMPLETED | PHASE1 | 2004-05 | 2004-05 | 2004-05 |
| NCT00649402 | Fed Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg | COMPLETED | PHASE1 | 2004-05 | 2004-06 | 2004-06 |
| NCT00648830 | Comparative Bioavailability Study of Clarithromycin 250 mg Tablets | COMPLETED | PHASE1 | 2004-05 | 2004-06 | 2004-06 |
| NCT00648622 | Fed Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mg | COMPLETED | PHASE1 | 2004-04 | 2004-04 | 2004-04 |
| NCT00120523 | 5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic Dermatitis | COMPLETED | PHASE3 | 2004-04 | 2010-10 | 2010-10 |
| NCT00648388 | Fasting Study of Cilostazol Tablets 100 mg and Pletal® Tablets 100 mg | COMPLETED | PHASE1 | 2004-03 | 2004-05 | 2004-05 |
| NCT00650416 | Fasting Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mg | COMPLETED | PHASE1 | 2004-03 | 2004-04 | 2004-04 |
| NCT00650234 | Fasting BE Study of Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR Tablets 500 mg | COMPLETED | PHASE1 | 2004-02 | 2004-03 | 2004-03 |
| NCT00648713 | Fed Study of Terbinafine Hydrochloride Tablets 250 mg and Lamisil® 250 mg | COMPLETED | PHASE1 | 2004-02 | 2004-03 | 2004-03 |
| NCT00649948 | Food BE Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage XR 500 mg | COMPLETED | PHASE1 | 2004-02 | 2004-06 | 2004-05 |
| NCT00647647 | Fasting Study of Terbinafine Hydrochloride Tablets 250 mg and Lamisil® Tablets 250 mg | COMPLETED | PHASE1 | 2004-02 | 2004-03 | 2004-03 |
| NCT00650195 | Fasting Study of Metolazone Tablets 10 mg and Zaroloxyn® Tablets 10 mg | COMPLETED | PHASE1 | 2004-02 | 2004-03 | 2004-02 |
| NCT00649350 | Food Study Metformin Hydrochloride ER Tablets 750 mg and Glucophage XR 750 mg | COMPLETED | PHASE1 | 2003-12 | 2003-12 | 2003-12 |
| NCT00649714 | Fed Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mg | COMPLETED | PHASE1 | 2003-12 | 2004-01 | 2004-01 |
| NCT00648518 | Fasting Study of Metformin Hydrochloride ER Tablets 750 mg and Glucophage® XR Tablets 750 mg | COMPLETED | PHASE1 | 2003-12 | 2003-12 | 2003-12 |
| NCT00647985 | Food Study of Fexofenadine Tablets 180 mg and Allegra® Tablets 180 mg | COMPLETED | PHASE1 | 2003-11 | 2003-11 | 2003-11 |
| NCT00648336 | Fasting Study of Mercaptopurine 50 mg and Purinethol® Tablets 50 mg | COMPLETED | PHASE1 | 2003-11 | 2003-12 | 2003-12 |
| NCT00650052 | Fasting Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mg | COMPLETED | PHASE1 | 2003-11 | 2003-12 | 2003-12 |
| NCT00647738 | Comparative Bioavailability Study of Baclofen 20 mg Tablets in Healthy Male Volunteers / Fasting State | COMPLETED | PHASE1 | 2003-10 | 2003-11 | 2003-11 |
| NCT00649376 | Fasting Study of Fexofenadine Tablets 180 mg and Allegra® Tablets 180 mg | COMPLETED | PHASE1 | 2003-10 | 2003-11 | 2003-11 |
| NCT00649181 | Fasting Study of Metolazone Tablets 5 mg and Zaroloxyn® Tablets 5 mg | COMPLETED | PHASE1 | 2003-10 | 2003-11 | 2003-11 |
| NCT00649506 | Food Study of Nitrofurantoin Macrocrystals 100 mg Capsules and Macrodantin® 100 mg | COMPLETED | PHASE1 | 2003-09 | 2003-09 | 2003-09 |
| NCT00189319 | To Evaluate the Impact of Oral Flecainide on Quality of Life in Patients With Paroxysmal Atrial Fibrillation | COMPLETED | PHASE4 | 2003-09 | | |
| NCT00648011 | Food Study of Quinapril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Accuretic™ Tablets 20 mg/25 mg | COMPLETED | PHASE1 | 2003-08 | 2003-09 | 2003-08 |
| NCT00649441 | Fasting Study of Quinapril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Accuretic™ Tablets 20 mg/25 mg | COMPLETED | PHASE1 | 2003-08 | 2003-09 | 2003-09 |
| NCT00649194 | Food Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Tablets 20 mg | COMPLETED | PHASE1 | 2003-08 | 2003-08 | 2003-08 |
| NCT00648583 | Food Study of Ondansetron Tablets 24 mg and Zofran® Tablets 24 mg | COMPLETED | PHASE1 | 2003-07 | 2003-07 | 2003-07 |
| NCT00648544 | Fed, Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Subjects | COMPLETED | PHASE1 | 2003-07 | 2003-07 | 2003-07 |
| NCT00649532 | Fasting Study of Ondansetron Tablets 24 mg and Zofran® Tablets 24 mg | COMPLETED | PHASE1 | 2003-07 | 2003-07 | 2003-07 |
| NCT00650221 | Fasting Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Normal Healthy Subjects | COMPLETED | PHASE1 | 2003-06 | 2003-07 | 2003-07 |
| NCT00648921 | Fasting Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mg | COMPLETED | PHASE1 | 2003-06 | 2003-07 | 2003-07 |
| NCT00647777 | Food Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mg | COMPLETED | PHASE1 | 2003-06 | 2003-07 | 2003-07 |
| NCT00649493 | Fed Study of Rabeprazole Sodium Tablets 20 mg and Aciphex® Tablets 20 mg | COMPLETED | PHASE1 | 2003-05 | 2003-06 | 2003-06 |
| NCT00647855 | Fasting Study of Levothyroxine Sodium Tablets 300 μg to Synthroid® Tablets 300 μg | COMPLETED | PHASE1 | 2003-05 | 2003-06 | 2003-06 |
| NCT00647972 | Fasting Study of Olanzapine Tablets 20 mg and Zyprexa® Tablets 20 mg | TERMINATED | PHASE1 | 2003-05 | | 2003-05 |
| NCT00648349 | Fasting Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Delayed-Release Tablets 20 mg | COMPLETED | PHASE1 | 2003-05 | 2003-06 | 2003-06 |
| NCT00189280 | Aldara for the Treatment of Large and/or Multiple sBCC | COMPLETED | PHASE3 | 2003-05 | 2007-10 | 2007-10 |
| NCT00649012 | Food Study of Pioglitazone HCl Tablets 45 mg to Actos® Tablets 45 mg | COMPLETED | PHASE1 | 2003-03 | 2003-03 | 2003-03 |
| NCT00649558 | Fasting Study of Pioglitazone HCl Tablets 45 mg and Actos® Tablets 45 mg | COMPLETED | PHASE1 | 2003-02 | 2003-03 | 2003-03 |
| NCT00648778 | Fasting Study of Loxapine Succinate Capsules 25 mg and Loxitane® Capsules 25 mg | COMPLETED | PHASE1 | 2003-01 | 2003-02 | 2003-02 |
| NCT00649233 | Food Study of Metoprolol Tartrate/Hydrochlorothiazide Tablets 100/50 mg to Lopressor HCT® Tablets 100/50 mg | COMPLETED | PHASE1 | 2003-01 | 2003-02 | 2003-02 |
| NCT00648765 | Fed Study of Anagrelide Hydrochloride Capsules 1 mg to Agrylin® Capsules 1 mg | COMPLETED | PHASE1 | 2003-01 | 2003-01 | 2003-01 |
| NCT00648024 | Fasting Study of Anagrelide Hydrochloride Capsules 1 mg to Agrylin® Capsules 1 mg | COMPLETED | PHASE1 | 2003-01 | 2003-01 | 2003-01 |
| NCT00648557 | Fasting Study of Levothyroxine Sodium Tablets 200 mg to Synthroid Tablets 200 mg | COMPLETED | PHASE1 | 2003-01 | 2003-03 | 2003-03 |
| NCT00649688 | Fasting Study of Metoprolol Tartrate/Hydrochlorothiazide Tablets 100/50 mg and Lopressor HCT® Tablets 100/50 mg | COMPLETED | PHASE1 | 2003-01 | 2003-02 | 2003-02 |
| NCT00649038 | Fed Study of Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Lotensin HCT® Tablets 20 mg/25 mg | COMPLETED | PHASE1 | 2002-12 | 2002-12 | 2002-12 |
| NCT00648843 | Food Study of Oxybutynin Chloride Extended-release Tablets 5 mg and Ditropan XL® Tablets 5 mg | COMPLETED | PHASE1 | 2002-12 | 2003-01 | 2002-12 |
| NCT00648271 | Fed Study of Metoprolol Tartrate Tablets 25 mg and Lopressor® 50 mg | COMPLETED | PHASE1 | 2002-12 | 2003-01 | 2002-12 |
| NCT00649103 | Fasting Study of Quinapril Hydrochloride Tablets 40 mg and Accupril® Tablets 40 mg | COMPLETED | PHASE1 | 2002-12 | 2003-01 | 2002-12 |
| NCT00648856 | Food Study of Sertraline Hydrochloride Tablets 100 mg and Zoloft® Tablets 100 mg | COMPLETED | PHASE1 | 2002-12 | 2003-01 | 2002-12 |
| NCT00649051 | Fasting Study of Metolazone Tablets 2.5 mg and Zaroloxyn® Tablets 2.5 mg | COMPLETED | PHASE1 | 2002-12 | 2003-01 | 2002-12 |
| NCT00649116 | Fed Study of Metoprolol Tartrate Tablets 100 mg and Lopressor® 100 mg | COMPLETED | PHASE1 | 2002-12 | 2003-01 | 2002-12 |
| NCT00649649 | Food Study of Quinapril Hydrochloride Tablets 40 mg and Accupril® Tablets 40 mg | COMPLETED | PHASE1 | 2002-12 | 2003-01 | 2002-12 |
| NCT00650481 | Fasting Study of Oxybutynin Chloride Extended-release Tablets 5 mg and Ditropan XL® Tablets 5 mg | COMPLETED | PHASE1 | 2002-12 | 2003-01 | 2002-12 |
| NCT00649857 | Food Study of Cetirizine HCl Tablets 10 mg and Zyrtec® 10 mg | COMPLETED | PHASE1 | 2002-11 | 2002-12 | 2002-12 |
| NCT00649597 | Fasting Study of Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Lotensin HCT® Tablets 20 mg/25 mg | COMPLETED | PHASE1 | 2002-11 | 2002-12 | 2002-12 |
| NCT00650065 | Fasting Study of Cetirizine HCl Tablets 10 mg and Zyrtec® Tablets 10 mg | COMPLETED | PHASE1 | 2002-11 | 2002-12 | 2002-12 |
| NCT00650325 | Study of Sertraline Hydrochloride Tablets 100 mg and Zoloft® Tablets 100 mg | COMPLETED | PHASE1 | 2002-11 | 2002-12 | 2002-12 |
| NCT00189267 | A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients | COMPLETED | PHASE2 | 2002-11 | 2005-09 | |
| NCT00650000 | Fasting Study of Modafinil Tablets 200 mg and Provigil® Tablets 200 mg | COMPLETED | PHASE1 | 2002-10 | 2002-10 | 2002-10 |
| NCT00649259 | Food Study of Oxybutynin Chloride ER Tablets 10 mg and Ditropan XL® Tablets 10 mg | COMPLETED | PHASE1 | 2002-10 | 2002-11 | 2002-11 |
| NCT00648492 | Food Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR 500 mg | COMPLETED | PHASE1 | 2002-10 | 2002-11 | 2002-11 |
| NCT00648440 | Food Study of Midodrine HCl Tablets 5 mg and ProAmatine® Tablets 5 mg | COMPLETED | PHASE1 | 2002-10 | 2002-11 | 2002-11 |
| NCT00649285 | Food Study of Nitrofurantoin Monohydrate/Macrocrystals Capsules 100 mg and Macrobid® Capsules 100 mg | COMPLETED | PHASE1 | 2002-10 | 2002-11 | 2002-11 |
| NCT00650312 | Fasting Study of Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR Tablets 500 mg | COMPLETED | PHASE1 | 2002-10 | 2002-11 | 2002-10 |
| NCT00650286 | Food Study of Modafinil Tablets 200 mg to Provigil® Tablets 200 mg | COMPLETED | PHASE1 | 2002-09 | 2002-10 | 2002-10 |
| NCT00650364 | Fasting Study of Midodrine HCl Tablets 5 mg and ProAmatine® Tablets 5 mg | COMPLETED | PHASE1 | 2002-08 | 2002-09 | 2002-08 |
| NCT00761371 | Imiquimod 5% Cream in the Treatment of External Genital or Perianal Warts in HIV+ Patients | COMPLETED | PHASE4 | 2002-08 | 2004-02 | 2004-02 |
| NCT01018342 | Fed Study of Mylan Nitrofurantoin Monohydrate/Macrocrystals Capsules 100 mg and Macrobid® Capsules 100 mg | COMPLETED | PHASE1 | 2002-07 | | 2002-08 |
| NCT00650013 | Fed Study of Midodrine HCl Tablets 5 mg and ProAmatine® Tablets 5 mg | COMPLETED | PHASE1 | 2002-07 | 2002-08 | 2002-08 |
| NCT00649129 | Fasting Study of Oxybutynin Chloride ER Tablets 10 mg and Ditropan XL® Tablets 10 mg | COMPLETED | PHASE1 | 2002-07 | 2002-08 | 2002-08 |
| NCT00649727 | Fed Study of Oxybutynin Chloride Extended-release Tablets 10 mg and Ditropan XL® Tablets 10 mg | COMPLETED | PHASE1 | 2002-07 | 2002-08 | 2002-07 |
| NCT00189241 | A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma | COMPLETED | PHASE3 | 2001-02 | 2007-02 | 2007-02 |
| NCT00977483 | Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) | COMPLETED | PHASE3 | 1998-05 | 2005-01 | 2005-01 |
| NCT00408473 | Comparative Study of Flecainide CR and Placebo in the Early Treatment of Atrial Fibrillation. | TERMINATED | PHASE4 | | | |